...
首页> 外文期刊>Emerging Infectious Diseases >Drug Resistance in Salmonella enterica ser. Typhimurium Bloodstream Infection, Malawi (http://wwwnc.cdc.gov/eid/article/20/11/14-1175)
【24h】

Drug Resistance in Salmonella enterica ser. Typhimurium Bloodstream Infection, Malawi (http://wwwnc.cdc.gov/eid/article/20/11/14-1175)

机译:肠沙门氏菌的耐药性。马拉维鼠伤寒血流感染(http://wwwnc.cdc.gov/eid/article/20/11/14-1175)

获取原文
           

摘要

To the Editor: Salmonella enterica serotype Typhimurium is one of the most common causes of bloodstream infection in sub-Saharan Africa (1). Among adults, the principal risk factor for invasive nontyphoidal Salmonella (iNTS) disease is advanced HIV infection; up to 44% of HIV-infected patients experience bacteremic recurrence through recrudescence of the original infection (2,3). Epidemics of iNTS disease in sub-Saharan Africa have been associated with a novel genotype of S. enterica ser. Typhimurium of multilocus sequence type (ST) 313 that is rarely seen outside the region and is associated with multidrug resistance (MDR) to chloramphenicol, cotrimoxazole, and ampicillin (4,5). As a consequence, ceftriaxone has become a key agent in the empirical management of nonfocal sepsis in Malawi (6).
机译:致编者:肠炎沙门氏菌血清型鼠伤寒沙门氏菌是撒哈拉以南非洲最常见的血液感染原因之一(1)。在成年人中,侵袭性非伤寒沙门氏菌(iNTS)疾病的主要危险因素是晚期HIV感染。高达44%的HIV感染患者会通过原始感染的复发而发生细菌复发(2,3)。在撒哈拉以南非洲,iNTS疾病的流行与一种新的肠炎链球菌基因型有关。鼠伤寒多位点序列类型(ST)313,在该区域外很少见,与氯霉素,cotrimoxazole和氨苄青霉素的多药耐药性(MDR)有关(4,5)。结果,头孢曲松酮已成为马拉维非局灶性败血症经验管理中的关键因素(6)。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号